StockNews.AI
VNDA
StockNews.AI
27 days

Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025

1. Vanda Pharmaceuticals will release Q2 2025 results on July 31, 2025. 2. A conference call will discuss financial results and corporate activities. 3. Investors must register early to join the conference call. 4. The call will be archived on Vanda's website for later access. 5. Vanda focuses on innovative therapies for unmet medical needs.

4m saved
Insight
Article

FAQ

Why Neutral?

The announcement is routine, lacking significant news that generally moves stock prices. Historical data indicates earnings calls often lead to volatility only if results vary widely from expectations.

How important is it?

The article contains key information regarding earnings, impacting investor sentiment, though lacking in major disruptive developments.

Why Short Term?

Earnings results will have immediate effects, particularly in pricing around release time. Past releases have impacted VNDA's stock price only in response to performance indicators.

Related Companies

VNDA
Conference Call and Webcast to Follow , /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2025 on Thursday, July 31, 2025, before the market opens.  Vanda will host a conference call at 8:00 AM ET on Thursday, July 31, 2025, during which management will discuss the second quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 9430387. The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software. A replay of the call will be available on Thursday, July 31, 2025, beginning at 11:00 AM ET and will be accessible until Thursday, August 7, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 9430387. About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma. Corporate Contact: Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc. 202-734-3400 [email protected]  Jim Golden / Jack Kelleher / Dan MooreCollected Strategies[email protected]  SOURCE Vanda Pharmaceuticals Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News